Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-03-26 00:00:00 ET · period of report 2026-03-26 · accession 0002043411-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-26 | 2026-03-26 | FENC | Cioffi Christiana Marie | Chief Strategy Off | M - OptEx | $4.23 | +4,700 | 4,700 | New | +$19.9K |
| D | 2026-03-26 | 2026-03-26 | FENC | Cioffi Christiana Marie | Chief Strategy Off | M - OptEx | $4.23 | -4,700 | 145.3K | -3% | -$19.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2026-03-26 | M | A | 4,700 | $4.23 | 4,700 | D | — | — | (F1) Shares acquired through the exercise of an option contract with strike price of $4.23 and an expiration date of November 13, 2034. |
| 2 | Derivative | Stock Options | 2026-03-26 | M | D | 4,700 | $4.23 | 145,300 | D | $4.23 · 2025-11-13 to 2034-11-13 | 4,700 Common Shares | (F1) Shares acquired through the exercise of an option contract with strike price of $4.23 and an expiration date of November 13, 2034. |